Treatment to Prevent Transmission of HIV-1

被引:133
作者
Cohen, Myron S. [1 ]
Gay, Cynthia L. [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC 27599 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SEXUAL RISK BEHAVIOR; FEMALE GENITAL-TRACT; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; RNA LEVELS; POSITIVE PATIENTS; SEMINAL PLASMA; GAY MEN;
D O I
10.1086/651478
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Antiretroviral therapy (ART) has the potential to prevent human immunodeficiency virus (HIV) transmission by reducing the concentration of HIV in blood and genital secretions. Indeed, mathematical models with favorable assumptions suggest the potential of ART to stop the spread of HIV infection. Empirical results from ecological and population-based studies and from several short-term observational studies involving HIV status-discordant heterosexual couples suggest that ART reduces the rate of HIV transmission. A multinational, randomized, controlled trial (National Institutes of Health HPTN052) examining the reliability and durability of ART as prevention of transmission in HIV status-discordant couples is under way. The latter and other studies also consider sexual risk-taking behavior and transmission of HIV-resistant variants when ART is used as prevention. Early HIV detection and treatment (ie, test and treat) are being considered as an important prevention strategy. In this article, we review the data supporting the use of ART to prevent HIV transmission and critically examine the public health implications of this strategy.
引用
收藏
页码:S85 / S95
页数:11
相关论文
共 114 条
[1]
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding [J].
Al-Harthi, L ;
Kovacs, A ;
Coombs, RW ;
Reichelderfer, PS ;
Wright, DJ ;
Cohen, MH ;
Cohn, J ;
Cu-Uvin, S ;
Watts, H ;
Lewis, S ;
Beckner, S ;
Landay, A .
AIDS, 2001, 15 (12) :1535-1543
[2]
Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade A human immunodeficiency virus type 1-infected women [J].
Andreoletti, Laurent ;
Skrabal, Katharma ;
Perrin, Virginie ;
Chomont, Nicolas ;
Saragosti, Sentob ;
Gresenguet, Gerard ;
Moret, Helene ;
Jacques, Jerome ;
Longo, Jean de Dieu ;
Matta, Mathieu ;
Mammano, Fabrizio ;
Belec, Laurent .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) :1838-1842
[3]
TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1 THROUGH HETEROSEXUAL CONTACTS [J].
ANGARANO, G ;
MONNO, L ;
APPICE, A ;
GIANNELLI, A ;
ROMANELLI, C ;
FICO, C ;
PASTORE, G .
AIDS, 1994, 8 (07) :1013-1014
[4]
[Anonymous], 17 C RETR OPP INF SA
[5]
[Anonymous], B MED SUISSES
[6]
[Anonymous], 17 C RETR OPP INF SA
[7]
[Anonymous], 2007, UN ACC SCAL PRIOR HI
[8]
Modelling the impact of antiretroviral use in resource-poor settings [J].
Baggaley, Rebecca F. ;
Garnett, Geoff P. ;
Ferguson, Neil M. .
PLOS MEDICINE, 2006, 3 (04) :493-504
[9]
Antiretroviral therapy and sexual behavior: A comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda [J].
Bateganya, M ;
Colfax, G ;
Shafer, LA ;
Kityo, C ;
Mugyenyi, P ;
Serwadda, D ;
Mayanja, H ;
Bangsberg, D .
AIDS PATIENT CARE AND STDS, 2005, 19 (11) :760-768
[10]
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models [J].
Blower, S ;
Bodine, E ;
Kahn, J ;
McFarland, W .
AIDS, 2005, 19 (01) :1-14